Corpus Intelligence IC Memo — HENRY COUNTY MEDICAL CENTER 2026-04-26 04:02 UTC
IC Memo — HENRY COUNTY MEDICAL CENTER
Investment Committee Memorandum | TN | 43 beds | Grade C | EBITDA uplift $6.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HENRY COUNTY MEDICAL CENTER

CCN 440132 | HENRY, TN | 43 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HENRY COUNTY MEDICAL CENTER is a 43-bed suburban community hospital in HENRY, TN with $81.7M in net patient revenue and a -13.0% operating margin. The hospital serves a payer mix of 32.8% Medicare, 22.6% Medicaid, and 44.6% commercial.

Thesis: Turnaround. Our ML models identify $6.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -13.0% to -5.7% (+736bps).

Net Revenue HCRIS$81.7M
Current EBITDA COMPUTED$-10.6M
Operating Margin COMPUTED-13.0%
Occupancy HCRIS55.6%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS28.6%
Distress Probability ML50.3%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
68
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -13.0% places it below the state median. Among 68 size-comparable peers (22-86 beds), the median margin is 0.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (22-86), prioritizing same-state peers. 68 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HENRY COUNTY MEDICAL CENTER (Target)TN43$81.7M-13.0%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
FRANKLIN WOODS COMMUNITY HOSPITN80$110.3M18.7%
GREENEVILLE COMMUNITY HOSPITALTN81$104.5M-5.1%
CUMBERLAND MEDICAL CENTERTN72$84.3M-12.0%
VANDERBILT TULLAHOMA-HARTON HOTN71$79.5M-8.2%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.7M+210bp18mo
Cost to Collect4.5%2.5%$1.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.6M+198bp12mo
A/R Days Reduction5200.0%3800.0%$994K+122bp9mo
Clean Claim Rate88.0%96.0%$52K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.7M
Cost to Collect
$1.6M
Denial Rate Reduction
$1.6M
A/R Days Reduction
$994K
Clean Claim Rate
$52K
Total EBITDA Uplift$6.0M
Current EBITDA$-10.6M
+ RCM Uplift+$6.0M
Pro Forma EBITDA$-4.6M
Current Margin-13.0%
Pro Forma Margin-5.7%
WC Released (1x)$3.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-16.4M$-10.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-16.4M$-16.4M0.00x-100.0%
Bull Case9.0x11.0x$-14.7M$-1.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-14.7M$-6.4M0.00x-100.0%
Bear Case11.0x10.0x$-18.0M$-34.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-18.0M$-44.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (22.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 50.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 68 hospitals with 22-86 beds
  • Same-state prioritization (n=69)
  • Comp margins: P25=-11.9% / P50=0.8% / P75=9.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.